ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has issued a public advisory on the use of Celia and Gromore on the global recall of few implicated batches by the principal manufacturer and importers as informed by the World Health Organisation (WHO).
According to DRAP spokesman on Sunday, these particular batches of Celia and Gromore being voluntary recalled were recommended for use in lactose intolerant infants.
Pursuant to the global recall, DRAP has taken prompt action and activated the Federal Inspectorate and Quality Assurance team for the removal of implicated batches from the market.
DRAP has collected the records of import transaction of these batches from France. The recall process has been initiated in collaboration with the provincial governments of Punjab, Sindh, Khyber Pakhtunkhwa, Balochistan, Gilgit, AJK and Islamabad Capital Territory administration, who are advised to monitor the recall process through their surveillance force.
